The anti-snoring devices and snoring surgery market has gained traction in the recent years due to growing consciousness about the ill effects of snoring and sleep apnea, and these treatments have become the central point of attention for clinical reasons.
Rising awareness across developed nations related to the ill effects of snoring and huge benefits of treatments coupled with rising count of geriatric and obese population are the factors that are expected to boost the market growth. Growing cigarette consumption and alcohol intake along with technological developments in designing in anti-snoring devices are also likely to foster the market growth. Lack of efficacy and scientific validation of the anti-snoring devices along with high cost of oral appliances for customized usage are the factors that may restrain the growth of this market. The demand of antisnoring treatments across developing countries is expected to create growth opportunities in this market.
The report segments the anti-snoring treatments market on the basis of types, surgical procedures and region. On the basis of type, the market is segmented into oral appliances/mouthpieces, nasal devices, position control devices, chin straps, and tongue-stabilizing devices (TSDs) and EPAP therapy devices. The Oral Appliances/Mouthpieces is segmented into mandibular advancement devices (MADS) and tongue-retaining devices (TRDS) whereas Nasal Devices is segmented into External Nasal Dilators (or Nasal Strips) and others. On the basis of surgical procedures market, the market is segmented into Uvulopalatopharyngoplasty (UPPP), Laser-Assisted Uvulopalatoplasty (LAUP), radiofrequency ablation (somnoplasty), pillar procedure, injection snoreplasty/sclerotherapy, palatal stiffening procedures and other anti-snoring surgical procedures. On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).
Key players operating in this market are Sleeping Well, LLC, Apnea Sciences Corporation, The Pure Sleep Company, Somnomed Limited, Airway Management Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, Glaxosmithkline, PLC., and Meditas Ltd.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS: